Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial and fungal cell membrane lipid bilayer is a vital semi-permeable barrier that separates the internal cytoplasm from the external environment, maintaining the electrochemical gradients necessary for ATP synthesis and nutrient transport (Source: Molecular Biology of the Cell, 6th ed.). In bacteria, the membrane is rich in anionic phospholipids like phosphatidylglycerol, which serves as a docking site for lipopeptide antibiotics like daptomycin (Source: StatPearls, Daptomycin). Fungal membranes are distinguished by the presence of ergosterol, a sterol that maintains membrane fluidity and is absent in mammalian cells, which use cholesterol instead (Source: Journal of Fungi, 2021). This biochemical difference is exploited by polyene antifungals like Amphotericin B, which bind ergosterol to form lethal transmembrane pores (Source: NIH, PubChem). Drugs targeting the lipid bilayer are often bactericidal or fungicidal because they cause rapid loss of cytoplasmic contents, such as potassium ions, leading to immediate metabolic arrest (Source: Nature Reviews Microbiology, 2017). However, the structural similarity between microbial and host membranes can lead to significant clinical toxicities, particularly nephrotoxicity seen with polymyxins and polyenes (Source: Clinical Infectious Diseases, 2019).
Disruption of membrane integrity through pore formation, depolarization, or binding to specific lipid components (e.g., ergosterol or phosphatidylglycerol), leading to leakage of essential intracellular ions and cell death.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and fungal cell membrane lipid bilayer.